MX354579B - Anillo vaginal que comprende meloxicam y un agente modulador de la liberacion del principio activo, util como anticonceptivo de uso continuo en mujeres. - Google Patents
Anillo vaginal que comprende meloxicam y un agente modulador de la liberacion del principio activo, util como anticonceptivo de uso continuo en mujeres.Info
- Publication number
- MX354579B MX354579B MX2014007523A MX2014007523A MX354579B MX 354579 B MX354579 B MX 354579B MX 2014007523 A MX2014007523 A MX 2014007523A MX 2014007523 A MX2014007523 A MX 2014007523A MX 354579 B MX354579 B MX 354579B
- Authority
- MX
- Mexico
- Prior art keywords
- release
- active principle
- women
- modulating
- continuous
- Prior art date
Links
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001929 meloxicam Drugs 0.000 title abstract 3
- 229940044953 vaginal ring Drugs 0.000 title abstract 3
- 239000006213 vaginal ring Substances 0.000 title abstract 3
- 239000003795 chemical substances by application Substances 0.000 title abstract 2
- 239000003433 contraceptive agent Substances 0.000 title abstract 2
- 230000002254 contraceptive effect Effects 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere al Anillo vaginal de liberación sostenida que comprende meloxicam y un agente modulador de la liberación del principio activo, tal como polivinilpirrolidona K-30, que libera el principio activo por al menos 90 días, útil como anticonceptivo de uso continuo en mujeres. El anillo vaginal comprende preferentemente 5% a 30% en peso de meloxicam, en relación al peso total de la formulación.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2011/056022 WO2013098591A1 (es) | 2011-12-29 | 2011-12-29 | Anillo vaginal que comprende meloxicam y un agente modulador de la liberación del principio activo, útil como anticonceptivo de uso continuo en mujeres |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014007523A MX2014007523A (es) | 2014-08-27 |
| MX354579B true MX354579B (es) | 2018-03-12 |
Family
ID=48696404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014007523A MX354579B (es) | 2011-12-29 | 2011-12-29 | Anillo vaginal que comprende meloxicam y un agente modulador de la liberacion del principio activo, util como anticonceptivo de uso continuo en mujeres. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9533050B2 (es) |
| EP (1) | EP2799043B1 (es) |
| JP (1) | JP5902318B2 (es) |
| KR (1) | KR101785414B1 (es) |
| CN (1) | CN104203169B (es) |
| BR (1) | BR112014015053A2 (es) |
| CA (1) | CA2860108C (es) |
| EA (1) | EA027564B1 (es) |
| MX (1) | MX354579B (es) |
| NI (1) | NI201400066A (es) |
| WO (1) | WO2013098591A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20155779A7 (fi) | 2015-10-30 | 2017-05-01 | Solani Therapeutics Ltd | Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu |
| EP3272333A1 (en) | 2016-07-22 | 2018-01-24 | Chemo Research, S.L. | Vaginal composition comprising a combination of estrogen and vitamin d |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0889724A1 (en) | 1996-02-27 | 1999-01-13 | Rpms Technology Limited | Cox-2 selective inhibitors for managing labour and uterine contractions |
| DE19608423A1 (de) | 1996-03-05 | 1997-09-11 | Merck Patent Gmbh | Implantate mit phasenweiser Arzneistoffabgabe |
| US6905701B2 (en) * | 1997-06-11 | 2005-06-14 | Umd, Inc. | Formulations for transmucosal vaginal delivery of bisphosphonates |
| US20050276836A1 (en) * | 1997-06-11 | 2005-12-15 | Michelle Wilson | Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents |
| US6197327B1 (en) | 1997-06-11 | 2001-03-06 | Umd, Inc. | Device and method for treatment of dysmenorrhea |
| JP4959907B2 (ja) * | 2001-03-27 | 2012-06-27 | ワーナー チルコット（アイルランド）リミティド | 抗菌剤投与のための膣内用ドラッグデリバリーデバイス |
| US7004171B2 (en) | 2002-02-25 | 2006-02-28 | Hi-Gienic Intra Vaginal Technologies Ltd. | System for transvaginal drug delivery |
| KR20040092649A (ko) | 2003-04-24 | 2004-11-04 | 엘지전자 주식회사 | 광디스크의 복사 방지 정보 관리방법 |
| ES2360806T3 (es) * | 2004-07-09 | 2011-06-09 | The Population Council, Inc. | Composiciones de liberación prolongada que contienen moduladores de receptores de progesterona. |
| DE102006027793A1 (de) * | 2006-06-16 | 2007-12-20 | Lts Lohmann Therapie-Systeme Ag | Opioid-Kombinations-Wafer |
| KR20090023729A (ko) * | 2006-06-23 | 2009-03-05 | 엘란 파마 인터내셔널 리미티드 | 나노입자형 멜록시캄 및 조절 방출형 하이드로코돈을 포함하는 조성물 |
| US20080026054A1 (en) * | 2007-04-27 | 2008-01-31 | Nectid Inc. | Novel anelgesic combination |
| CA2730995C (en) * | 2008-07-17 | 2016-11-22 | Micell Technologies, Inc. | Drug delivery medical device |
| US20100087402A1 (en) * | 2008-09-29 | 2010-04-08 | Vivus, Inc. | Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders |
-
2011
- 2011-12-29 CN CN201180076297.4A patent/CN104203169B/zh not_active Expired - Fee Related
- 2011-12-29 EA EA201491167A patent/EA027564B1/ru not_active IP Right Cessation
- 2011-12-29 CA CA2860108A patent/CA2860108C/en not_active Expired - Fee Related
- 2011-12-29 US US14/367,678 patent/US9533050B2/en not_active Expired - Fee Related
- 2011-12-29 EP EP11879093.0A patent/EP2799043B1/en not_active Not-in-force
- 2011-12-29 WO PCT/IB2011/056022 patent/WO2013098591A1/es not_active Ceased
- 2011-12-29 KR KR1020147020217A patent/KR101785414B1/ko not_active Expired - Fee Related
- 2011-12-29 JP JP2014549543A patent/JP5902318B2/ja not_active Expired - Fee Related
- 2011-12-29 MX MX2014007523A patent/MX354579B/es active IP Right Grant
- 2011-12-29 BR BR112014015053A patent/BR112014015053A2/pt not_active Application Discontinuation
-
2014
- 2014-06-20 NI NI201400066A patent/NI201400066A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015503544A (ja) | 2015-02-02 |
| EP2799043A4 (en) | 2015-08-05 |
| US9533050B2 (en) | 2017-01-03 |
| MX2014007523A (es) | 2014-08-27 |
| CN104203169B (zh) | 2016-07-13 |
| EP2799043B1 (en) | 2019-11-27 |
| EA027564B1 (ru) | 2017-08-31 |
| CN104203169A (zh) | 2014-12-10 |
| KR101785414B1 (ko) | 2017-10-16 |
| EA201491167A1 (ru) | 2014-12-30 |
| KR20140112040A (ko) | 2014-09-22 |
| JP5902318B2 (ja) | 2016-04-13 |
| CA2860108C (en) | 2016-10-04 |
| NI201400066A (es) | 2017-03-13 |
| US20150328319A1 (en) | 2015-11-19 |
| WO2013098591A1 (es) | 2013-07-04 |
| BR112014015053A2 (pt) | 2017-06-13 |
| CA2860108A1 (en) | 2013-07-04 |
| EP2799043A1 (en) | 2014-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX392839B (es) | Liberacion autorregulada de ingrediente farmaceutico activo. | |
| MX2016010213A (es) | Formulaciones farmaceuticas novedosas. | |
| EA201291372A1 (ru) | Фармацевтическая композиция, содержащая дроспиренон, и набор для предупреждения зачатия | |
| MX2016014320A (es) | Composiciones de suspension de liberacion prolongada. | |
| NZ602111A (en) | Extended release formulations of rasagiline and uses thereof | |
| CU24065B1 (es) | Forma de dosificación farmacéutica que comprende nifedipino y un antagonista de angiotensina ii | |
| IN2012MN02923A (es) | ||
| MX348823B (es) | Formulaciones estables de linaclotida. | |
| IN2014KN02324A (es) | ||
| PH12015501096A1 (en) | Composition for immediate and extended release | |
| MY191875A (en) | Solid dosage form | |
| PH12015501982A1 (en) | Pharmaceutical compositions comprising everolimus | |
| MY159492A (en) | Solid pharmaceutical formulation with delayed release | |
| NZ714288A (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
| MX2013012364A (es) | Composicion y metodo para mejorar la estabilidad fisica de formulaciones agricolas en suspension basadas en aceite. | |
| EP2575842A4 (en) | COMPOSITION COMPRISING THE EXTRACT OF PHYSALIS ALKEKENGI VAR. FRANCHETI HORT AS AN ACTIVE INGREDIENT FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES | |
| AR095691A1 (es) | FORMULACIÓN DE L-5-METILTETRAHIDROFOLATO DE CALCIO AMORFO (L-5-MTHF-Ca), PROCEDIMIENTO, USO | |
| WO2014056824A3 (en) | Oral care composition | |
| WO2012064302A3 (en) | Improved montelukast formulations | |
| MX359713B (es) | Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas. | |
| MX2014007523A (es) | Anillo vaginal que comprende meloxicam y un agente modulador de la liberacion del principio activo, util como anticonceptivo de uso continuo en mujeres. | |
| GEP201706696B (en) | Method for treating gynecological diseases | |
| MX376014B (es) | Composicion para el cuidado bucal. | |
| IN2012CH05549A (es) | ||
| IN2014CN04119A (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: LABORATORIOS ANDROMACO, S.A. (EX INVERSIONES GRUCH |
|
| FG | Grant or registration |